Search for Merck & Co Inc and
    1. August 8, 2016

      Allergan setback prompts healthcare slide

      Healthcare stocks in the US slid on Monday in a lacklustre trading session as investors digested disappointing results...

    2. August 5, 2016

      Bristol-Myers’ value plunges as cancer drug fails

      A new blockbuster cancer drug Bristol-Myers Squibb hoped would become a replacement for chemotherapy in most lung...

    Special Reports

    1. Inventions and Patents

      Patenting has never been more popular. Applications have reached record levels at the ...
    2. Combating Cancer

      We consider the latest in cell therapy and efforts to arm the immune system in the fig...
    Search more Special Reports on this topic.

    1. August 1, 2016

      Nanoco lands key deal as Merck signs on quantum dotted line

      Nanoco has made a significant commercial breakthrough with its quantum-dot technology for displays, signing up Merck as...

    2. June 17, 2016

      Wall Street endures second straight weekly loss

      US stocks suffered a second straight weekly decline on Friday, weighed down by the technology and healthcare sectors....

    3. June 2, 2016

      Brakes off in effort to confront melanoma

      Thanks to its terrible prognosis, melanoma was once known as the cancer that gave others a bad name. Now a type of...

    4. June 2, 2016

      President raises patient and business hope for cancer treatment

      When Jimmy Carter was diagnosed last year with melanoma that had spread to his brain, many people feared the worst for...

    5. June 1, 2016

      Cancer doctors face next drug challenge

      More than 30,000 doctors and scientists will gather in Chicago this weekend for the biggest annual meeting of cancer...

    6. May 19, 2016

      Pull together to prevent a superbug apocalypse

      Jim O’Neill, UK Treasury minister and former Goldman Sachs economist, has focused the world’s attention on...

    7. Fast FT

      May 19, 2016

      Merck KGaA boosted by acquisition in Q1

      Merck KGaA saw a substantial rise in both sales and profits in the first quarter, the first period in which a recent...

    8. May 9, 2016

      Pfizer to trial triple-combination cancer treatment

      Pfizer plans to test a combination of three novel cancer drugs in humans next year, as the US drugmaker seeks to make...

    9. Fast FT

      May 5, 2016

      Merck raises underlying earnings guidance

      US drugmaker Merck has raised its full year guidance for underlying earnings per share despite sales edging down 1 per...

    10. April 26, 2016

      Tony Coles – on a mission to tackle Alzheimer’s

      After brokering the $10bn sale of the biotech company he led, Tony Coles planned to follow the well-trodden path of...

    11. February 1, 2016

      Finance sector pay shifts from bonuses to salaries, says Mercer survey

      The world’s banks, insurers and investment managers continued to cut staff bonuses last year in favour of increasing...

    12. January 31, 2016

      Gilead risks becoming victim of its own success

      During the past two years, Gilead, a California-based drugmaker, has emerged as the undisputed leader of the four large...

    13. January 29, 2016

      Merck launches hepatitis C drug price war

      Merck has launched a price war in the treatment of hepatitis C by setting the list price of its new drug at a 40 per...

    14. January 25, 2016

      Brexit would be a ‘mistake’, say global pharma leaders

      A British exit from the EU would isolate the country’s scientists and reduce its influence in medicine, global...

    15. January 23, 2016

      Why the Disrupted are privately griping about tech upstarts at Davos

      Given the theme of this year’s World Economic Forum was the Fourth Industrial Revolution, it was natural that Silicon...

    16. January 15, 2016

      Merck of Germany wins UK support in battle with US namesake

      Merck of Germany has won the backing of a UK court in its battle with Merck of the US over the family name shared by...

    17. December 15, 2015

      Sanofi/Boehringer: swap shop

      Swapping assets was a form of human trade since long before bankers and their fees arrived on the scene. In...

    18. December 14, 2015

      AstraZeneca: in search of a blockbuster

      Jimmy Carter can tell you why AstraZeneca is contemplating paying $5bn for an unquoted Dutch biotech company with a...

    19. FT Alphaville

      December 4, 2015

      Relypsa: the next US biotech M&A target?

      StreetInsider.com reports: Merck & Co (NYSE: MRK) plans to make a non-binding offer to acquire Relypsa, (Nasdaq: RLYP),...

    20. December 1, 2015

      Eli Lilly and Merck bolstered by upgrades

      Pharmaceutical stocks received a shot in the arm after analysts at Barclays upgraded Eli Lilly and Merck citing...

    21. November 26, 2015

      Unhealthy drugs: Pharma struggles with its reputation

      An industry dedicated to saving and extending lives might be expected to find empathy easy. Instead, some of the...

    22. November 22, 2015

      Pfizer-Allergan tie-up would mark M&A high point

      Pfizer’s imminent $150bn takeover of Allergan to create the world’s biggest drugmaker will mark a fresh pinnacle in an...

    23. November 13, 2015

      Animal health: double or quits

      Sea lice. Fowl pox. Swine fever. Foot-and-mouth. Animal diseases often take prosaic names. This does not make them...

    24. October 12, 2015

      Eli Lilly’s heart-drug setback reverberates through pharma sector

      Shares of several of the US’s largest drugmakers were roiled on Monday after Eli Lilly surprisingly halted development...

    25. October 12, 2015

      Eli Lilly shares sink as it scraps heart drug

      Eli Lilly has pulled the plug on a potential blockbuster medicine intended to ward off heart attacks and strokes,...

    26. October 9, 2015

      Scots nurse ‘serious’ with Ebola after-effects as epidemic fades

      A Scottish nurse suffering the after-effects of Ebola was readmitted to an isolation unit on Friday — highlighting...

    27. September 7, 2015

      Groundbreaking cancer drug given NHS approval

      A groundbreaking new cancer drug that harnesses the immune system to kill tumours has been recommended for use by the...

    28. September 7, 2015

      The hedgefundification of bond funds

      Bill Gross, the bond king-in-exile at Janus Capital, may not have attracted as many investors as he hoped to follow him...

    29. July 31, 2015

      Health experts hail Ebola breakthrough

      Public health experts have hailed a “turning point” in the fight against Ebola, after preliminary results for an...

    30. July 23, 2015

      Volunteers find it hard to put their skills to good use

      LinkedIn made a surprising discovery when it launched an online service for executives wanting to use their skills to...

    31. July 12, 2015

      Drugmakers premiere summer blockbusters

      Blockbuster drugs are back. A wave of new multibillion-dollar medicines for heart disease and high cholesterol, added...

    32. June 11, 2015

      Printing whole organs remains a long way off

      Three dimensional printing is already being used to manufacture everything from simple plastic figurines to complex...

    33. May 31, 2015

      Clinical trials show cancer drug combo boosts survival rate

      A combination of two “immunotherapy” medicines made by Bristol-Myers Squibb can dramatically improve the chances of...

    34. May 15, 2015

      The drugs to watch in fight against cancer

      About 30,000 doctors and scientists will arrive in Chicago in two weeks for the annual meeting of the American Society...

    35. May 5, 2015

      Global spending on cancer drugs surges to $100bn

      Global annual spending on cancer drugs has hit $100bn for the first time as the pharmaceuticals industry prepares to...

    36. May 3, 2015

      A tale of two Mercks: Confusion mounts over shared brand name

      Merck of Germany is to step up investment in its brand to defend the company’s rights to the 347-year-old name it...

    37. April 28, 2015

      Investors sour on Coach turnround efforts

      Investors soured on Coach despite its turnround efforts after the retailer reported fiscal third-quarter results that...

    38. April 28, 2015

      Pfizer cuts forecasts as strong dollar bites

      Pfizer on Tuesday became the latest US drugmaker to warn a strengthening dollar was hurting its performance as it cut...

    Search for Merck & Co Inc and